IQ Consortium
Organization of pharmaceutical and biotechnology companies with a mission of advancing science and technology.
* New Date* Presented by the Pediatric Working Group Sponsored by the Drug Product Leadership Group People vary widely in how bitter they perceive medicines to be, which can impact how easily they take them. A global study from the Monell Chemical Senses Center found that genetic ancestry influences how bitter certain medicines taste and […]
*New Date!* Presented by: IQ Dissolution Working Group Sponsored by: IQ Drug Product Leadership Group In vitro dissolution testing is commonly performed to ensure that oral solid dosage medicines are of high quality and will achieve their targeted in vivo performance. However, this testing is time and material-consuming. Therefore, pharmaceutical companies have been developing predictive […]
Presented by the Pediatric Working Group Sponsored by the Drug Product Leadership Group Speaker: Mary Short Moderator: Elizabeth Galella, Bristol Myers Squibb (Description forthcoming) This is a public webinar. Membership in the IQ Consortium is not required to attend.
Presented by the Pediatric Working Group Sponsored by the Drug Product Leadership Group Speakers: Anna Externbrink, MSD and and Yemin Liu, AbbVie Moderator: Elizabeth Galella, Bristol Myers Squibb The use of soft foods and liquids as vehicles for drug administration can significantly enhance palatability and acceptability in pediatric patients, thereby improving therapeutic outcomes. In vitro assessments […]
